Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean category antidepressive agent an group approved?
Displaying drugs 201 - 225 of 10294 in total

Alpha-1-proteinase inhibitor

Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.
Approved
Matched Categories: … Antifibrinolytic Agents …

Nitrazepam

A benzodiazepine derivative used as an anticonvulsant and hypnotic.
Approved
Matched Description: … A benzodiazepine derivative used as an anticonvulsant and hypnotic. …
Matched Categories: … GABA Agents ... Anti-Anxiety Agents ... Tranquilizing Agents ... Neurotransmitter Agents ... Central Nervous System Agents …

Vecuronium

Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other...
Approved
Investigational
Matched Description: … reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents …
Matched Categories: … Cholinergic Agents ... Anticholinergic Agents ... Neuromuscular Agents ... Neurotransmitter Agents ... Neuromuscular Blocking Agents …

Amcinonide

Amcinonide is a corticosteroid.
Approved
Matched Categories: … Corticosteroids, Potent (Group III) ... Anti-Inflammatory Agents ... Immunosuppressive Agents ... Hyperglycemia-Associated Agents …

Rifamycin

Rifamycin is the prime member of the rifamycin family which are represented by drugs that are a product of fermentation from the gram-positive bacterium Amycolatopsis mediterranei, also known as Streptomyces mediterranei. The parent compound of rifamycin was rifamycin B which was originally obtained as a main product in the presence...
Approved
Investigational
Matched Description: … [A39986] Rifamycin was further developed by Cosmo Technologies Ltd and approved in November 16, 2018 …
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents ... Antirheumatic Agents ... Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents …

Salicylic acid

A compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics.
Approved
Investigational
Vet approved
Matched Categories: … Antifungal Agents ... Anti-Infective Agents ... Keratolytic Agents ... Nephrotoxic agents ... Agents causing hyperkalemia …

Silver sulfadiazine

Silver sulfadiazine is a sulfa derivative topical antibacterial used primarily on second- and third-degree burns.
Approved
Vet approved
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents ... Anti-Infective Agents, Local …

Fluoxymesterone

An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.
Approved
Illicit
Matched Description: … An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males …
Matched Categories: … Anabolic Agents …

Naxitamab

Naxitamab (humanized 3F8, hu3F8) is an IgG1 monoclonal antibody directed against the oncofetal differentiation antigen GD2 disialoganglioside.[L24454,A224604] Normally expressed during fetal development and in mature neurons, pain fibers, and skin cells, GD2 constitutes a highly efficient target in the treatment of neuroblastoma - it is widely expressed across and within...
Approved
Matched Description: … Naxitamab (humanized 3F8, hu3F8) is an IgG1 monoclonal antibody directed against the oncofetal differentiation ... [A224604] The first anti-GD2-monoclonal IgG antibody to be approved by the FDA for the treatment of …
Matched Categories: … Neurotoxic agents ... Antineoplastic Agents ... Agents that produce hypertension ... Antineoplastic and Immunomodulating Agents …

Zuranolone

Zuranolone is a neuroactive steroid that acts as a positive allosteric modulator of the GABAA receptors. Unlike other more common GABAA positive allosteric modulators on the market like benzodiazepines, zuranolone can modulate both synaptic and extrasynaptic GABAA conductance due to binding to a non-benzodiazepine site on the receptor.[A260776,A260786] Zuranolone was...
Approved
Experimental
Matched Description: … [A260791] Zuranolone was approved by the FDA on August 4th, 2023, and it is currently the only approved ... pharmacological profile of a neuroactive steroid in mind while also possessing a pharmacokinetics profile of an …
Matched Categories: … Antidepressive Agents ... Central Nervous System Agents …

Elm

Elm is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Matched Description: … It is not an approved drug. …

Turmeric

Turmeric is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Investigational
Matched Description: … It is not an approved drug. …
Matched Categories: … Protective Agents …

Eleuthero

Eleuthero is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Matched Description: … It is not an approved drug. …

Ustekinumab

Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses. It was generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice. It is a targeted biologic disease-modifying anti-rheumatic drug (bDMARDs) that...
Approved
Investigational
Matched Description: … In September 2016, ustekinumab was additionally approved for the management of moderate to severe Crohn's ... Ustekinumab is currently the first and only approved biologic therapy for ulcerative colitis that targets ... The therapeutic use of the drug started in Canada, the US, and Europe since 2009 when it was first approved …
Matched Categories: … Immunomodulatory Agents ... Immunosuppressive Agents ... Skin and Mucous Membrane Agents ... Antineoplastic and Immunomodulating Agents …

Suprofen

An ibuprofen-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. It is no longer approved for use in the United States.
Approved
Withdrawn
Matched Description: … It is no longer approved for use in the United States. ... An ibuprofen-type anti-inflammatory analgesic and antipyretic. ... It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. …
Matched Categories: … Nephrotoxic agents ... Antirheumatic Agents ... Anti-Inflammatory Agents ... Agents causing hyperkalemia ... Sensory System Agents …

Rimexolone

Rimexolone is a 1% eye drop solution is a glucocorticoid steroid. It is used to treat inflammation in the eye. It is marketed as Vexol.
Approved
Matched Categories: … Anti-Inflammatory Agents ... Immunosuppressive Agents ... Hyperglycemia-Associated Agents …

Zileuton

Leukotrienes are substances that induce numerous biological effects including augmentation of neutrophil and eosinophil migration, neutrophil and monocyte aggregation, leukocyte adhesion, increased capillary permeability, and smooth muscle contraction. These effects contribute to inflammation, edema, mucus secretion, and bronchoconstriction in the airways of asthmatic patients. Zileuton relieves such symptoms through its...
Approved
Investigational
Withdrawn
Matched Categories: … Anti-Inflammatory Agents ... Sensory System Agents ... Agents to Treat Airway Disease ... Peripheral Nervous System Agents …

Bupropion

Bupropion (also known as the brand name product Wellbutrin®) is a norepinephrine/dopamine-reuptake inhibitor (NDRI) used most commonly for the management of Major Depressive Disorder (MDD), Seasonal Affective Disorder (SAD), and as an aid for smoking cessation. Bupropion exerts its pharmacological effects by weakly inhibiting the enzymes involved in the uptake...
Approved
Matched Description: … commonly for the management of Major Depressive Disorder (MDD), Seasonal Affective Disorder (SAD), and as an ... [A6399,A178810] Bupropion was originally classified as an "atypical" antidepressant because it does ... [A178816] Bupropion is sometimes used as an add-on agent to first-line treatments of depression such …
Matched Categories: … Antidepressive Agents ... Antidepressive Agents Indicated for Depression ... Dopamine Agents ... Photosensitizing Agents ... Smoking Cessation Agents …

Scutellaria lateriflora

Scutellaria lateriflora is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Matched Description: … It is not an approved drug. …

Saw palmetto

Saw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Investigational
Matched Description: … It is not an approved drug. …
Matched Categories: … Urological Agents ... Genitourinary Agents …

Pemigatinib

Pemigatinib is a small molecule kinase inhibitor with antitumour activity. It works by inhibiting fibroblast growth factor receptors (FGFRs), which are receptor tyrosine kinases that activate signalling pathways in tumour cells. FGFRs gained attention as potential therapeutic targets in selected cancers, as FGFR gene alterations were observed in a wide...
Approved
Investigational
Matched Description: … FDA-approved test. ... with a fibroblast growth factor receptor 2 (FGFR2) gene fusion or other rearrangements as detected by an ... [A198963] The FDA-approved indication for pemigatinib was granted under accelerated approval based on …
Matched Categories: … Antineoplastic Agents ... Antineoplastic and Immunomodulating Agents …

Ciprofloxacin

Ciprofloxacin is a second generation fluoroquinolone that has spawned many derivative antibiotics. It is formulated for oral, intravenous, intratympanic, ophthalmic, and otic administration for a number of bacterial infections.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] The first ciprofloxacin containing product was FDA approved on 22 October 1987.
Approved
Investigational
Matched Description: … L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] The first ciprofloxacin containing product was FDA approved …
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents ... Agents Causing Muscle Toxicity ... QTc Prolonging Agents ... Photosensitizing Agents …
Matched Products: … Truemed Group LLC …

Rimonabant

Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved...
Approved
Investigational
Matched Description: … It is an inverse agonist for the cannabinoid receptor CB1. ... Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. ... Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. …
Matched Categories: … Anti-Obesity Agents ... Agents producing tachycardia ... Neurotransmitter Agents …

Docetaxel

Docetaxel is a clinically well established anti-mitotic chemotherapy medication used for the treatment of different types of cancer, including breast, ovarian, and non-small cell lung cancer. Docetaxel is a complex diterpenoid molecule and a semisynthetic analogue of paclitaxel.[A259676,L46466] Docetaxel reversibly binds to microtubulin with high affinity in a 1:1 stoichiometric...
Approved
Investigational
Matched Description: … [L46466] Docetaxel was approved by the FDA in 1996 and is available in solution for injection for intravenous ... [A259676] Compared to paclitaxel, docetaxel is two times more potent as an inhibitor of microtubule depolymerization …
Matched Categories: … Antimitotic Agents ... Antineoplastic Agents ... Hepatotoxic Agents ... Agents Causing Muscle Toxicity ... Myelosuppressive Agents …

Larix sibirica wood

Larix sibirica wood is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Matched Description: … It is not an approved drug. …
Displaying drugs 201 - 225 of 10294 in total